tiprankstipranks
Advertisement
Advertisement

DE:2H51 Stock Latest News

Ocugen doses first patient in OCU410 trial
The FlyOcugen doses first patient in OCU410 trial
6d ago
OCGN
Ocugen’s Earnings Call Highlights Risk-Reward Inflection
PremiumCompany Announcements
Ocugen’s Earnings Call Highlights Risk-Reward Inflection
18d ago
OCGN
Ocugen: Buy Rating Reaffirmed as Cash Runway Extends to 2028 and Ophthalmology Pipeline Advances; $11 Price Target Maintained
PremiumRatings
Ocugen: Buy Rating Reaffirmed as Cash Runway Extends to 2028 and Ophthalmology Pipeline Advances; $11 Price Target Maintained
1M ago
OCGN
Ocugen: Buy Rating Reaffirmed as Late-Stage OCU410/OCU400 Programs Advance; $10 Price Target Maintained
PremiumRatings
Ocugen: Buy Rating Reaffirmed as Late-Stage OCU410/OCU400 Programs Advance; $10 Price Target Maintained
1M ago
OCGN
Ocugen reports Q2 EPS (7c), consensus (5c)
PremiumThe Fly
Ocugen reports Q2 EPS (7c), consensus (5c)
1M ago
OCGN
Is OCGN a Buy, Before Earnings?
PremiumPre-EarningsIs OCGN a Buy, Before Earnings?
1M ago
OCGN
Ocugen granted RMAT designation for OCU410
Premium
The Fly
Ocugen granted RMAT designation for OCU410
1M ago
OCGN
OCGN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
OCGN Upcoming Earnings Report: What to Expect?
1M ago
OCGN
Ocugen inks OCU400 licensing deal for MENA
PremiumCompany Announcements
Ocugen inks OCU400 licensing deal for MENA
2M ago
8K
OCGN
Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical
PremiumThe Fly
Ocugen announces $4M OCU400 license agreement with Roots Pharmaceutical
2M ago
OCGN
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
CGC
CPB
Ocugen Stockholders Approve Proposals and Confirm Leadership
PremiumCompany Announcements
Ocugen Stockholders Approve Proposals and Confirm Leadership
3M ago
8K
OCGN
Ocugen Consolidates Financial Leadership Under New Accounting Officer
PremiumCompany AnnouncementsOcugen Consolidates Financial Leadership Under New Accounting Officer
3M ago
8K
OCGN
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
NFE
YSS
Ocugen price target lowered to $11 from $12 at Canaccord
Premium
The Fly
Ocugen price target lowered to $11 from $12 at Canaccord
3M ago
OCGN
Ocugen Raises $130 Million Through Convertible Notes Offering
PremiumCompany Announcements
Ocugen Raises $130 Million Through Convertible Notes Offering
4M ago
8K
OCGN
Ocugen Announces Interim Chief Medical Officer Appointment Transition
PremiumCompany Announcements
Ocugen Announces Interim Chief Medical Officer Appointment Transition
4M ago
8K
OCGN
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
PremiumRatings
Ocugen Maintained at Buy as Analyst Cites Compelling Gene Therapy Data and Keeps $12 Price Target Unchanged
4M ago
OCGN
Ocugen Raises Capital Through Convertible Senior Notes Offering
PremiumCompany Announcements
Ocugen Raises Capital Through Convertible Senior Notes Offering
4M ago
8K
OCGN
Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
PremiumCompany AnnouncementsOcugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
4M ago
8K
OCGN
Ocugen reports Q1 EPS (6c), consensus (5c)
Premium
The Fly
Ocugen reports Q1 EPS (6c), consensus (5c)
4M ago
OCGN
Ocugen Announces Private Convertible Notes Offering to Deleverage
Premium
Company Announcements
Ocugen Announces Private Convertible Notes Offering to Deleverage
4M ago
8K
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >